=big gap in share price between now and then “IF”
Short term I see no reason why we won’t see pre COVID sh price here $3, trial appears to be going well throughout and markets are moving in the right direction as apposed to pre COVID
Only thing changed is we are now cashed up for 2591 and progressed 6 months further into phase 3 Trof
Given CEO confirmed again Acadia just has to replicate phase 2 trial with Trof seems to be certain amount of confidence.
Lots of action to come here over next 12 months or so it would seem!
Ann: Approval received for final stage of NNZ-2591 clinical trial, page-22
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.21 |
Change
-0.270(1.74%) |
Mkt cap ! $1.944B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $8.268M | 543.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.24 | 220 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |